committed dose
≈ 10 min read
Names in other languages
- Englishcommitted dose
- Românădoză angajată
- العربيةجرعة مودعة
- 中文待积有效剂量当量
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
The committed dose in radiological protection is a measure of the stochastic health risk due to an intake of radioactive material into the human body. Stochastic in this context is defined as the probability of cancer induction and genetic damage, due to low levels of radiation. The SI unit of measure is the sievert. A committed dose from an internal source represents the same effective risk as the same amount of effective dose applied uniformly to the whole body from an external source, or the same amount of equivalent dose applied to part of the body.
The committed dose is not intended as a measure for deterministic effects, such as radiation sickness, which are defined as the severity of a health effect which is certain to happen. The radiation risk proposed by the International Commission on Radiological Protection (ICRP) predicts that an effective dose of one sievert carries a 5.5% chance of developing cancer. Such a risk is the sum of both internal and external radiation dose.
The committed dose in radiological protection is a measure of the stochastic health risk due to an intake of radioactive material into the human body. Stochastic in this context is defined as the probability of cancer induction and genetic damage, due to low levels of radiation. The SI unit of measure is the sievert. A committed dose from an internal source represents the same effective risk as the same amount of effective dose applied uniformly to the whole body from an external source, or the same amount of equivalent dose applied to part of the body.
The committed dose is not intended as a measure for deterministic effects, such as radiation sickness, which are defined as the severity of a health effect which is certain to happen. The radiation risk proposed by the International Commission on Radiological Protection (ICRP) predicts that an effective dose of one sievert carries a 5.5% chance of developing cancer. Such a risk is the sum of both internal and external radiation dose.
ICRP definition
The ICRP states "Radionuclides incorporated in the human body irradiate the tissues over time periods determined by their physical half-life and their biological retention within the body. Thus they may give rise to doses to body tissues for many months or years after the intake. The need to regulate exposures to radionuclides and the accumulation of radiation dose over extended periods of time has led to the definition of committed dose quantities". The ICRP defines two dose quantities for individual committed dose.
Committed equivalent dose is "the time integral of the equivalent dose rate in a particular tissue or organ that will be received by an individual following intake of radioactive material into the body by a Reference Person". This refers specifically to the dose in a specific tissue or organ, in the similar way to external equivalent dose. Committed effective dose is "the sum of the products of the committed organ or tissue equivalent doses and the appropriate tissue weighting factors W T [...].
The commitment period is taken to be 50 years for adults, and to age 70 years for children." This refers specifically to the dose to the whole body, in the similar way to external effective dose. The committed effective dose is used to demonstrate compliance with dose limits and is entered into the "dose of record" for occupational exposures used for recording, reporting and retrospective demonstration of compliance with regulatory dose limits.
The ICRP further states "For internal exposure, committed effective doses are generally determined from an assessment of the intakes of radionuclides from bioassay measurements or other quantities (e.g., activity retained in the body or in daily excreta). The radiation dose is determined from the intake using recommended dose coefficients".
Measurement
There is no direct way to measure committed dose. Estimates can be made by analyzing the data from whole body counting, blood samples, urine samples, fecal samples, biopsies, and measurement of intake.
Whole body counting (WBC) is the most direct approach, but has some limitations: it cannot detect beta emitters such as tritium; it provides no chemical information about any compound that the radioisotope may be bound to; it may be inconclusive regarding the nature of the radioisotope detected; and it is a complex measurement subject to many sources of measurement and calibration error.
Analysis of blood samples, urine samples, fecal samples, and biopsies can provide more exact information about the chemical and isotopic nature of the contaminant, its distribution in the body, and the rate of elimination. Urine samples are the standard way to measure tritium intake, while fecal samples are the standard way to measure transuranic intake. If the nature and quantity of radioactive materials taken into the body is known, and a reliable biochemical model of this material is available, this can be sufficient to determine committed dose.
In occupational or accident scenarios, approximate estimates can be based on measurements of the environment that people were exposed to, but this cannot take into account factors such as breathing rate and adherence to hygiene practices. Exact information about the intake and its biochemical impact is usually only available in medical situations where radiopharmaceuticals are measured in a radioisotope dose calibrator prior to injection.
Annual limit on intake (ALI) is the derived limit for the amount of radioactive material taken into the body of an adult worker by inhalation or ingestion in a year. ALI is the intake of a given radionuclide in a year that would result in: a committed effective dose equivalent of 0.02 Sv (2 rems) for a "reference human body", or a committed dose equivalent of 0.2 Sv (20 rems) to any individual organ or tissue, whatever dose is the smaller.
Health effects
Intake of radioactive materials into the body tends to increase the risk of cancer, and possibly other stochastic effects. The International Commission on Radiological Protection has proposed a model whereby the incidence of cancers increases linearly with effective dose at a rate of 5.5% per sievert. This model is widely accepted for external radiation, but its application to internal contamination has been disputed.
This model fails to account for the low rates of cancer in early workers at Los Alamos National Laboratory who were exposed to plutonium dust, and the high rates of thyroid cancer in children following the Chernobyl accident . The informal European Committee on Radiation Risk has questioned the ICRP model used for internal exposure.
However a UK National Radiological Protection Board report endorses the ICRP approaches to the estimation of doses and risks from internal emitters and agrees with CERRIE conclusions that these should be best estimates and that associated uncertainties should receive more attention. The true relationship between committed dose and cancer is almost certainly non-linear.
For example, iodine-131 is notable in that high doses of the isotope are sometimes less dangerous than low doses, since they tend to kill thyroid tissues that would otherwise become cancerous as a result of the radiation. Most studies of very-high-dose I-131 for treatment of Graves' disease have failed to find any increase in thyroid cancer, even though there is linear increase in thyroid cancer risk with I-131 absorption at moderate doses. Internal exposure of the public is controlled by regulatory limits on the radioactive content of food and water.
These limits are typically expressed in becquerel/kilogram, with different limits set for each contaminant. Intake of very large amounts of radioactive material can cause acute radiation syndrome (ARS) in rare instances. Examples include the Alexander Litvinenko poisoning and Leide das Neves Ferreira. While there is no doubt that internal contamination was the cause of ARS in these cases, there is not enough data to establish what quantities of committed dose might cause ARS symptoms.
In most scenarios where ARS is a concern, the external effective radiation dose is usually much more hazardous than the internal dose. Normally, the greatest concern with internal exposure is that the radioactive material may stay in the body for an extended period of time, "committing" the subject to accumulating dose long after the initial exposure has ceased.
Over a hundred people, including Eben Byers and the radium girls, have received committed doses in excess of 10 Gy and went on to die of cancer or natural causes, whereas the same amount of acute external dose would invariably cause an earlier death by ARS.
Examples
Below are a series of examples of internal exposure. Thorotrast The exposure caused by Potassium-40 present within a normal person. The exposure to the ingestion of a soluble radioactive substance, such as 89 Sr in cows' milk. A person who is being treated for cancer by means of an unsealed source radiotherapy method where a radioisotope is used as a drug (usually a liquid or pill). A review of this topic was published in 19991.
Because the radioactive material becomes intimately mixed with the affected object it is often difficult to decontaminate the object or person in a case where internal exposure is occurring. While some very insoluble materials such as fission products within a uranium dioxide matrix might never be able to truly become part of an organism, it is normal to consider such particles in the lungs and digestive tract as a form of internal contamination which results in internal exposure.
Boron neutron capture therapy (BNCT) involves injecting a boron-10 tagged chemical that preferentially binds to tumor cells. Neutrons from a nuclear reactor are shaped by a neutron moderator to the neutron energy spectrum suitable for BNCT treatment. The tumor is selectively bombarded with these neutrons. The neutrons quickly slow down in the body to become low energy thermal neutrons.
These thermal neutrons are captured by the injected boron-10, forming excited (boron-11) which breaks down into lithium-7 and a helium-4 alpha particle both of these produce closely spaced ionizing radiation. This concept is described as a binary system using two separate components for the therapy of cancer. Each component in itself is relatively harmless to the cells, but when combined for treatment they produce a highly cytocidal (cytotoxic) effect which is lethal (within a limited range of 5-9 micrometers or approximately one cell diameter).
Clinical trials, with promising results, are currently carried out in Finland and Japan.
See also
Internal dosimetry Radioactivity Ionizing radiation Collective dose Total effective dose equivalent Cumulative dose Committed dose equivalent
References
US nuclear regulatory commission glossary Argonne national laboratory glossary Limitation of Exposure to Ionizing Radiation (Report No. 116). National Council on Radiation Protection and Measurements (NCRP).
External links
UK Govt COMARE website Uk Govt CERRIE website - "The confusing world of radiation dosimetry" - M.A. Boyd, 2009, U.S. Environmental Protection Agency. An account of chronological differences between USA and ICRP dosimetry systems.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372089607 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “committed dose” publication date (×1) · confidence 0.95 revision URL